Hexagon Nutrition: Chairman & Executive Director Arun Kelkar Completes Term
Mr. Arun Kelkar, Chairman & Executive Director of Hexagon Nutrition Limited, has completed his term and ceased to hold office on September 28, 2026. The Board acknowledged his contributions and leadership.
The cessation of a director upon completion of their term is a standard corporate event and is unlikely to have a significant short-term or long-term impact on the company's operations or financial performance.
The announcement is a routine update regarding the completion of a director's term and does not contain any information that would positively or negatively impact the company's outlook.
Hexagon Nutrition Limited has announced the cessation of Mr. Arun Kelkar, Chairman & Executive Director, upon completion of his term on September 28, 2026, effective from the close of office hours on that date.
The Board of Directors has expressed their deep appreciation and gratitude to Mr. Kelkar for his significant contributions, guidance, and leadership to the company since its inception.
The company has submitted the necessary disclosures as per Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This information will also be made available on the company's official website.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.